Abstract
Abstract
Purpose
This study aimed to evaluate trefoil factor 3 (TFF3), secreted frizzled-related protein 4 (sFRP4), reactive oxygen species modulator 1 (Romo1) and nuclear factor kappa B (NF-κB) as diagnostic and prognostic markers of endometrial cancer (EC) and ovarian cancer (OC).
Methods
Thirty-one patients with EC and 30 patients with OC undergone surgical treatment were enrolled together with 30 healthy controls in a prospective study. Commercial ELISA kits determined serum TFF-3, Romo-1, NF-кB and sFRP-4 concentrations.
Results
Serum TFF-3, Romo-1 and NF-кB levels were significantly higher in patients with EC and OC than those without cancer. Regarding EC, none of the serum biomarkers differs significantly between endometrial and non-endometrioid endometrial carcinomas. Mean serum TFF-3 and NF-кB levels were significantly higher in advanced stages. Increased serum levels of TFF-3 and NF-кB were found in those with a higher grade of the disease. Regarding OC, none of the serum biomarkers differed significantly among histological subtypes. Significantly increased serum levels of NF-кB were observed in patients with advanced-stage OC than those with stage I and II diseases. No difference in serum biomarker levels was found between those who had a recurrence and those who had not. The sensibility and specificity of these four biomarkers in discriminating EC and OC from the control group showed encouraging values, although no one reached 70%.
Conclusions
TFF-3, Romo-1, NF-кB and SFRP4 could represent new diagnostic and prognostic markers for OC and EC. Further studies are needed to validate our results.
Funder
Istanbul University-Cerrahpasa, School of Medicine, Turkey,
Publisher
Springer Science and Business Media LLC
Subject
Obstetrics and Gynecology,General Medicine
Reference55 articles.
1. Torre LA, Trabert B, DeSantis CE, Miller KD, Samimi G, Runowicz CD et al (2018) Ovarian cancer statistics, 2018. CA Cancer J Clin 68(4):284–296
2. Cancer Research UK. Cancer Research UK Uterine Cancer Statistics 2014 [Available from: https://www.cancerresearchuk.org/health-professional/cancer-statistics/statistics-by-cancer-type/uterine-cancer/incidence#heading-One
3. Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A (2018) Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 68(6):394–424
4. Della Corte L, Giampaolino P, Mercorio A, Riemma G, Schiattarella A, De Franciscis P et al (2020) Sentinel lymph node biopsy in endometrial cancer: state of the art. Transl Cancer Res 9(12):7725–7733
5. National Cancer Institute [Internet]. Bethesda, MD: National Cancer Institute (US); [cited 2018]. NCI Dictionaries; [cited 2018]. Available from: http://www.cancer.gov/cancertopics/cancerlibrary/terminologyresources/ncidictionaries; NCI Dictionary of Cancer Terms: http://www.cancer.gov/dictionary
Cited by
4 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献